Literature DB >> 22507923

Asymptomatic carotid artery stenosis: identification of subgroups with different underlying plaque characteristics.

G W van Lammeren1, A G den Hartog, G Pasterkamp, A Vink, J-P P M de Vries, F L Moll, G J de Borst.   

Abstract

OBJECTIVES: Optimal surgical treatment of patients with asymptomatic carotid artery stenosis (ACAS) remains a matter of debate. Established definitions of ACAS include: (1) patients who never suffered from ipsilateral cerebrovascular events (group 1) or (2) patients who suffered from ipsilateral cerebrovascular events more than 6 months prior to revascularisation (group 2). Cerebrovascular symptoms are closely related to underlying carotid plaque composition and therefore we investigated potential plaque differences between these definition-based subgroups.
DESIGN: Cross-sectional analysis of a longitudinal prospective biobank study.
MATERIAL AND METHODS: Carotid atherosclerotic plaques from 264 asymptomatic patients were harvested during endarterectomy, and subjected to histopathological examination. Patients were divided into two groups: group 1: truly asymptomatic (n = 182), and group 2: patients with ipsilateral events more than 6 months before carotid endarterectomy (CEA) (n = 82).
RESULTS: Patients in group 1 had relatively more stable plaque characteristics as compared with patients in group 2, with a higher median plaque smooth muscle cell content (2.1 (0.0-18.7) vs. 1.6 (0.0-14.4); P = 0.036), a higher proportion of heavily calcified plaques (67.7% (123/182) vs. 48.8% (40/82); P = 0.005) and less frequently intraplaque haemorrhages (11.5% (21/182) vs. 30.5% (25/82); P = 0.001).
CONCLUSION: Different plaque characteristics within subgroups of ACAS patients can be identified based on reported past ipsilateral events, which might result in adjusted future treatment strategies.
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22507923     DOI: 10.1016/j.ejvs.2012.03.011

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

Review 1.  Has our understanding of calcification in human coronary atherosclerosis progressed?

Authors:  Fumiyuki Otsuka; Kenichi Sakakura; Kazuyuki Yahagi; Michael Joner; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-20       Impact factor: 8.311

2.  MR imaging-detected carotid plaque hemorrhage is stable for 2 years and a marker for stenosis progression.

Authors:  R J Simpson; S Akwei; A A Hosseini; S T MacSweeney; D P Auer; N Altaf
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-05       Impact factor: 3.825

3.  Quest for the Vulnerable Atheroma: Carotid Stenosis and Diametric Strain--A Feasibility Study.

Authors:  Canxing Xu; Chun Yuan; Edward Stutzman; Gador Canton; Keith A Comess; Kirk W Beach
Journal:  Ultrasound Med Biol       Date:  2015-12-23       Impact factor: 2.998

4.  Association of Neutrophil/Lymphocyte Ratio with Plaque Morphology in Patients with Asymptomatic Intermediate Carotid Artery Stenosis.

Authors:  İsa Öner Yüksel; Erkan Köklü; Şakir Arslan; Göksel Çağırcı; Eylem Özaydın Göksu; Pınar Koç; Serkan Çay; Filiz Kızılırmak
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

5.  Pre-operative Carotid Plaque Echolucency Assessment has no Predictive Value for Long-Term Risk of Stroke or Cardiovascular Death in Patients Undergoing Carotid Endarterectomy.

Authors:  D de Waard; G J de Borst; R Bulbulia; H Pan; A Halliday
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-06-23       Impact factor: 7.069

Review 6.  Calcifying Matrix Vesicles and Atherosclerosis.

Authors:  Dimitry A Chistiakov; Veronika A Myasoedova; Alexandra A Melnichenko; Andrey V Grechko; Alexander N Orekhov
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

7.  Consistency of superb microvascular imaging and contrast-enhanced ultrasonography in detection of intraplaque neovascularization: A meta-analysis.

Authors:  Fang Yang; Cong Wang
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.